All Publications
-
Abstract 17013: CTX320: An Investigational in vivo CRISPR-Based Therapy Efficiently and Durably Reduces Lipoprotein (a) Levels in Non-Human Primates After a Single Dose
Circulation
2023; 148
View details for DOI 10.1161/circ.148.suppl_1.17013